A NOVEL NQO1 SPECIFIC ANTI-TUMOR AGENT, SBSC-S3001, SELECTIVELY REGRESSES THE GROWTH OF TUMORS WITH HIGH NQO1 EXPRESSION

被引:0
|
作者
Yun, Minhyuk [1 ]
Kim, Goo-Young [1 ]
Jo, Sang Woo [1 ]
In, Changhoon [1 ]
Moon, Gyu-Young [1 ]
Ko, In Seok [2 ]
Lee, Eun Ju [2 ]
Hong, Yong Rae [2 ]
Lee, Whee Seong [2 ]
Cho, Helen [1 ]
机构
[1] Samyang Biopharmaceut Corp, Pangyo, South Korea
[2] Lmito Therapeut Inc, Pangyo, South Korea
关键词
D O I
10.1136/jitc-2020-SITC2020.0734
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
734
引用
收藏
页码:A439 / A439
页数:1
相关论文
共 46 条
  • [41] SINGLE-AGENT ANTI-TUMOR ACTIVITY IN RELAPSED/REFRACTORY SOLID TUMORS: INTERIM DATA FROM THE PHASE 1 SOLID TUMOR TRIAL OF AMV564, A NOVEL T-CELL ENGAGER
    Piha-Paul, Sarina
    Starodub, Alexander
    Karim, Raghad
    Shafique, Michael
    Suarez, Gabriel Tinoco
    Ruegg, Curtis
    Smith, Victoria
    Chun, Patrick
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A226 - A227
  • [42] RETRACTED: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer(Retracted article. See vol. 36, pg. 2920, 2017)
    Patrick, Brad A.
    Jaiswal, Anil K.
    CANCER RESEARCH, 2012, 72
  • [43] RETRACTED: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer (Retracted article. See vol. 36, pg. 2920, 2017)
    Patrick, B. A.
    Jaiswal, A. K.
    ONCOGENE, 2012, 31 (40) : 4362 - 4371
  • [44] Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatographic assay for the novel bio-reductive anti-tumor agent RH1 in human and mouse plasma
    Khan, P
    Abbas, S
    Hargreaves, RHJ
    Caffrey, R
    Megram, V
    McGown, A
    JOURNAL OF CHROMATOGRAPHY B, 1999, 729 (1-2): : 287 - 295
  • [45] CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents
    Perino, Samantha
    Kirby, R. Jason
    Agafonov, Roman
    Chaturvedi, Prasoon
    Eron, Scott
    Good, Andrew
    Hart, Ashley
    He, Minsheng
    Lobbardi, Riadh
    Phillips, Andrew J.
    Proia, David
    Henderson, James
    Thomeius, Michael
    Nasveschuk, Christopher
    Fisher, Stewart L.
    Pollock, Roy Macfarlane
    BLOOD, 2022, 140 : 11575 - 11575
  • [46] Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction
    Wang, Yuji
    Kang, Guifeng
    Liu, Jiawang
    Zhao, Ming
    Wu, Jianhui
    Zhang, Xiaoyi
    Li, Ye
    Zhong, Xiaobo
    Yang, Yifan
    Peng, Shiqi
    METALLOMICS, 2012, 4 (05) : 441 - 447